✦ LIBER ✦

Biopharmaceutical aspects of lipid formulations of amphotericin B

✍ Scribed by G. Storm; E. van Etten

Publisher: Springer
Year: 1997
Tongue: English
Weight: 943 KB
Volume: 16
Category: Article
ISSN: 0934-9723
DOI: 10.1007/bf01575123

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lipid formulations of amphotericin B: wh

Lipid formulations of amphotericin B: where are we today?

✍ A. Antoniadou; B. Dupont 📂 Article 📅 2005 🏛 Masson Editeur 🌐 French ⚖ 206 KB

Amphotericin B deoxycholate (AmBD) was introduced 45 years ago for the treatment of invasive mycoses, on the basis of open-label non comparative data. Throughout these years of use it proved to be a life-saving drug but also a toxic compound which under current approval criteria might not meet licen

Effect of nystatin, amphotericin B and a

Effect of nystatin, amphotericin B and amphotericin B methyl ester onSaccharomyces cerevisiaewith different lipid composition

✍ Maria Aperecida Resende; Flávio Alterhum 📂 Article 📅 1990 🏛 Springer Netherlands 🌐 English ⚖ 636 KB

Saccharomyces cerevisiae was cultured under anaerobiosis in semi-complete medium to which either palmitoleic or oleic acid was added. Cells were grown at 20 degrees C or 30 degrees C. The levels of total lipids, total sterols, and phospholipids were higher in cells grown at 20 degrees C than at 30 d

Lipid-based amphotericin B in the treatm

Lipid-based amphotericin B in the treatment of cryptococcosis

✍ M. A. Viviani; A. M. Tortorano; A. M. Roverselli; G. Rizzardini; A. Capetti; M. 📂 Article 📅 1994 🏛 Springer-Verlag 🌐 English ⚖ 633 KB

In vitro and in vivo antifungal activiti

In vitro and in vivo antifungal activities of liposomal amphotericin B, and amphotericin B lipid complex

✍ Kotaro Mitsutake; Shigeru Kohno; Yoshitsugu Miyazaki; Tetsuhiro Noda; Haruko Miy 📂 Article 📅 1994 🏛 Springer Netherlands 🌐 English ⚖ 454 KB

Formulation and characterization of amph

Formulation and characterization of amphotericin B–polyethylenimine–dextran sulfate nanoparticles

✍ Waree Tiyaboonchai; James Woiszwillo; C. Russell Middaugh 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 236 KB

A new aqueous nanoparticle system has been developed using complex coacervation employing the oppositely charged polymers polyethylenimine (PEI) and dextran sulfate (DS), with zinc sulfate as a stabilizing agent. Amphotericin B (AmB) was loaded into the nanoparticles as a model drug. The nanoparticl

Itraconazole added to a lipid formulatio

Itraconazole added to a lipid formulation of amphotericin B does not improve outcome of primary treatment of invasive aspergillosis

✍ Dimitrios P. Kontoyiannis; Maha Boktour; Hend Hanna; Harrys A. Torres; Ray Hache 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

## Abstract ## BACKGROUND Invasive aspergillosis (IA) is associated with poor outcome in patients with hematologic malignancy treated with amphotericin B (AMB)‐based therapy. Itraconazole (ITC), a triazole with activity against __Aspergillus__, has been used in combination with AMB or lipid formul